Cite
The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research
MLA
Robert Reinhard, et al. “The Evaluation of Risk-Benefit Ratio for Gut Tissue Sampling in HIV Cure Research.” Journal of Virus Eradication, vol. 3, no. 4, Oct. 2017, pp. 212–17. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4b2e7a6df34a2de4458baa42f2b79c94&authtype=sso&custid=ns315887.
APA
Robert Reinhard, Nicolas Chomont, Bertrand Lebouché, Cecilia T. Costiniuk, Jose Sousa, Rayoun Ramendra, Éric A. Cohen, Vikram Mehraj, Peter Ghali, Jean-Pierre Routy, Petronela Ancuta, & Rosalie Ponte. (2017). The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research. Journal of Virus Eradication, 3(4), 212–217.
Chicago
Robert Reinhard, Nicolas Chomont, Bertrand Lebouché, Cecilia T. Costiniuk, Jose Sousa, Rayoun Ramendra, Éric A. Cohen, et al. 2017. “The Evaluation of Risk-Benefit Ratio for Gut Tissue Sampling in HIV Cure Research.” Journal of Virus Eradication 3 (4): 212–17. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4b2e7a6df34a2de4458baa42f2b79c94&authtype=sso&custid=ns315887.